Statera Biopharma, Inc.: accounts_receivable
| Value | {"amount": 806438, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2012-03-31) |
| Status | current |
| Entity | Statera Biopharma, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T12:34:08.365203+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/85977259-82c8-4fc5-bcac-42f2b987a3ab
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001171843-12-001717 · Open the official SEC filing →Retrieved: 2026-08-19T12:34:08.365203+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001318641/accounts-receivable/2012-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/85977259-82c8-4fc5-bcac-42f2b987a3ab
History
- no predecessors — first report